Identification of biomarkers associated with the onset or progression of different types of diseases.
Genetic barcoding and Next Generation Sequencing (NGS) to evaluate sensitivity and efficiency of diagnosis by liquid biopsy in triple negative breast cancer and high grade gliomas
Scientists: Malatesta P., Ceresa D.
Developing high-throughput methods for the clinical implementation of drug screenings on single patients and the design of combined therapies
Scientists: Ceresa D.
Identification of new biomarkers in the sera of patients affected by cardiovascular and autoimmune diseases
Scientists: Furfaro A.L., Nitti M., Traverso N.
Identification and validation of new biomarkers associated with sepsis
Scientists: Furfaro A.L., Traverso N.
Characterization of proteins, metabolites and lipids profile of main biological fluids such as serum, plasma, urine, cerebrospinal fluid and their extracellular vesicles as source of diagnostic and prognostic biomarkers
Scientists: Bruschi M.
Evaluation of autoantibodies' role in the pathogenesis and progression of renal damage in patients affected by primitive glomerulonephritis
Scientists: Bruschi M.
Proteome profile characterization of extracellular vesicles released from cell culture under different conditions and evaluation of their role in the intercellular communication and regulation of cell microenvironment
Scientists: Bruschi M.
Proteome profile characterization of extracellular vesicles released from cell culture under different conditions and evaluation of their role in the intercellular communication and regulation of cell microenvironment
Scientists: Bruschi M.